Literature DB >> 25048875

Impact of the perioperative neutrophil-to-lymphocyte ratio on the long-term survival following an elective resection of colorectal carcinoma.

Toru Kubo1, Satoshi Ono, Hideki Ueno, Eiji Shinto, Junji Yamamoto, Kazuo Hase.   

Abstract

PURPOSES: The present study was designed to evaluate the prognostic value of the perioperative neutrophil-to-lymphocyte ratio (NLR) for the long-term survival in patients with colorectal cancer.
METHODS: This was a retrospective study of 524 patients with histologically proven stage II or III colorectal cancer who underwent curative colorectal resection. We classified patients into a low NLR group or high NLR group base on their NLR values at three time points (before surgery (Pre), on the first postoperative day (POD1), and on the third or fourth postoperative day (POD3)) and evaluated the survival according to the group.
RESULTS: The cancer-specific survival was significantly longer in the groups with a low NLR on POD3. The disease-free survival was significantly longer in the group with a low NLR on Pre. We subsequently allocated a score of 1 to patients with a high NLR at each point and reclassified patients into those with a low perioperative NLR group (score of 0 or 1) and high perioperative NLR group (score of 2 or 3). Both the cancer-specific survival and disease-free survival rates were significantly different between the two perioperative NLR groups. Both univariate and multivariate analyses demonstrated that being in the high perioperative NLR group was an independent risk factor for both the cancer-specific survival and disease-free survival.
CONCLUSIONS: Not only the preoperative but also the postoperative NTR is thus considered to be a predictor of the long-time survival in patients with colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25048875     DOI: 10.1007/s00384-014-1964-1

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  31 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Manipulation of the small intestine as a cause of the increased inflammatory response after open compared with laparoscopic surgery.

Authors:  N Hiki; N Shimizu; H Yamaguchi; K Imamura; K Kami; K Kubota; M Kaminishi
Journal:  Br J Surg       Date:  2006-02       Impact factor: 6.939

3.  Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill.

Authors:  R Zahorec
Journal:  Bratisl Lek Listy       Date:  2001       Impact factor: 1.278

4.  The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.

Authors:  Byung Kyu Park; Yong-Han Paik; Jeong Youp Park; Kyung Hwa Park; Seungmin Bang; Seung Woo Park; Jae Bock Chung; Young Nyun Park; Si Young Song
Journal:  Am J Clin Oncol       Date:  2006-04       Impact factor: 2.339

Review 5.  Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis.

Authors:  Alexander Mirnezami; Reza Mirnezami; Kandiah Chandrakumaran; Kishore Sasapu; Peter Sagar; Paul Finan
Journal:  Ann Surg       Date:  2011-05       Impact factor: 12.969

6.  A preoperative neutrophil to lymphocyte ratio of 3 predicts disease-free survival after curative elective colorectal cancer surgery.

Authors:  George Malietzis; Marco Giacometti; Alan Askari; Subramanian Nachiappan; Robin H Kennedy; Omar D Faiz; Omer Aziz; John T Jenkins
Journal:  Ann Surg       Date:  2014-08       Impact factor: 12.969

7.  Increased surgical stress promotes tumor metastasis.

Authors:  Yasunori Tsuchiya; Shigeaki Sawada; Isaku Yoshioka; Yasukata Ohashi; Mitsuhiro Matsuo; Yuko Harimaya; Kazuhiro Tsukada; Ikuo Saiki
Journal:  Surgery       Date:  2003-05       Impact factor: 3.982

Review 8.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

9.  Laparoscopic surgery induced interleukin-6 levels in serum and gut mucosa: implications of peritoneum integrity and gas factors.

Authors:  John M Luk; Peter H Tung; Kwong-Fai Wong; Kwong-Leung Chan; Simon Law; John Wong
Journal:  Surg Endosc       Date:  2008-04-29       Impact factor: 4.584

10.  Lymphocytic infiltration and survival in rectal cancer.

Authors:  J R Jass
Journal:  J Clin Pathol       Date:  1986-06       Impact factor: 3.411

View more
  15 in total

1.  Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal Cancer.

Authors:  Yu Sunakawa; Dongyun Yang; Shu Cao; Wu Zhang; Miriana Moran; Stephanie H Astrow; Jack Hsiang; Craig Stephens; Akihito Tsuji; Takehiro Takahashi; Hiroaki Tanioka; Yuji Negoro; Akinori Takagane; Satoshi Tani; Tatsuro Yamaguchi; Tetsuya Eto; Masashi Fujii; Wataru Ichikawa; Heinz-Josef Lenz
Journal:  Clin Colorectal Cancer       Date:  2018-08-23       Impact factor: 4.481

2.  Risk scores as useful predictors of perioperative complications in patients with rectal cancer who received radical surgery.

Authors:  Hiroshi Miyakita; Sotaro Sadahiro; Gota Saito; Kazutake Okada; Akira Tanaka; Toshiyuki Suzuki
Journal:  Int J Clin Oncol       Date:  2016-10-25       Impact factor: 3.402

3.  Prognostic efficacy of inflammation-based markers in patients with curative colorectal cancer resection.

Authors:  Özgür Akgül; Erdinç Çetinkaya; Metin Yalaza; Sabri Özden; Mesut Tez
Journal:  World J Gastrointest Oncol       Date:  2017-07-15

Review 4.  Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis.

Authors:  Randy C Bowen; Nancy Ann B Little; Joshua R Harmer; Junjie Ma; Luke G Mirabelli; Kyle D Roller; Andrew Mackay Breivik; Emily Signor; Alec B Miller; Hung T Khong
Journal:  Oncotarget       Date:  2017-05-09

5.  Combined Detection of Preoperative Neutrophil-to-Lymphocyte Ratio and CEA as an Independent Prognostic Factor in Nonmetastatic Patients Undergoing Colorectal Cancer Resection Is Superior to NLR or CEA Alone.

Authors:  Xiaoli Zhan; Xiaobo Sun; Yonggang Hong; Yuedong Wang; Kefeng Ding
Journal:  Biomed Res Int       Date:  2017-06-08       Impact factor: 3.411

6.  Neutrophil-to-lymphocyte ratio as a predictor of postoperative morbidity in patients with distal cholangiocarcinoma.

Authors:  Yusuke Kumamoto; Takashi Kaizu; Hiroshi Tajima; Nobuyuki Nishizawa; Shigenori Ei; Kazuharu Igarashi; Masahiko Watanabe
Journal:  Mol Clin Oncol       Date:  2018-08-14

7.  NLR and BRCA mutational status in patients with high grade serous advanced ovarian cancer.

Authors:  Claudia Marchetti; Marco D'Indinosante; Carolina Bottoni; Chiara Di Ilio; Stefano Di Berardino; Barbara Costantini; Angelo Minucci; Laura Vertechy; Giovanni Scambia; Anna Fagotti
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

8.  The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.

Authors:  Ross D Dolan; Jason Lim; Stephen T McSorley; Paul G Horgan; Donald C McMillan
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

9.  Combined use of preoperative lymphocyte counts and the post/preoperative lymphocyte count ratio as a prognostic marker of recurrence after curative resection of stage II colon cancer.

Authors:  Seiichi Shinji; Yoshibumi Ueda; Takeshi Yamada; Michihiro Koizumi; Yasuyuki Yokoyama; Goro Takahashi; Masahiro Hotta; Takuma Iwai; Keisuke Hara; Kohki Takeda; Mikihiro Okusa; Hayato Kan; Eiji Uchida
Journal:  Oncotarget       Date:  2017-12-20

10.  The predictive value of the ratio of the product of neutrophils and hemoglobin to lymphocytes in non-muscular invasive bladder cancer patients with postoperative recurrence.

Authors:  Ruining Zhao; Jiahao Shan; Lihong Nie; Xiaobo Yang; Zhongyu Yuan; Haoran Xu; Ziyang Liu; Xiaojie Zhou; Wenzhuo Ma; Hongbin Shi
Journal:  J Clin Lab Anal       Date:  2021-06-29       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.